BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22956583)

  • 1. Ganglioside inhibition of CD8+ T cell cytotoxicity: interference with lytic granule trafficking and exocytosis.
    Lee HC; Wondimu A; Liu Y; Ma JS; Radoja S; Ladisch S
    J Immunol; 2012 Oct; 189(7):3521-7. PubMed ID: 22956583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells.
    Shen DT; Ma JS; Mather J; Vukmanovic S; Radoja S
    J Leukoc Biol; 2006 Oct; 80(4):827-37. PubMed ID: 16891618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C delta localizes to secretory lysosomes in CD8+ CTL and directly mediates TCR signals leading to granule exocytosis-mediated cytotoxicity.
    Ma JS; Haydar TF; Radoja S
    J Immunol; 2008 Oct; 181(7):4716-22. PubMed ID: 18802074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The exocytosis of lytic granules is impaired in Vti1b- or Vamp8-deficient CTL leading to a reduced cytotoxic activity following antigen-specific activation.
    Dressel R; Elsner L; Novota P; Kanwar N; Fischer von Mollard G
    J Immunol; 2010 Jul; 185(2):1005-14. PubMed ID: 20543108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis.
    Le Floc'h A; Jalil A; Vergnon I; Le Maux Chansac B; Lazar V; Bismuth G; Chouaib S; Mami-Chouaib F
    J Exp Med; 2007 Mar; 204(3):559-70. PubMed ID: 17325197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for endobrevin/VAMP8 in CTL lytic granule exocytosis.
    Loo LS; Hwang LA; Ong YM; Tay HS; Wang CC; Hong W
    Eur J Immunol; 2009 Dec; 39(12):3520-8. PubMed ID: 19830729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntaxin7 is required for lytic granule release from cytotoxic T lymphocytes.
    Pattu V; Qu B; Marshall M; Becherer U; Junker C; Matti U; Schwarz EC; Krause E; Hoth M; Rettig J
    Traffic; 2011 Jul; 12(7):890-901. PubMed ID: 21438968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins.
    Peña SV; Hanson DA; Carr BA; Goralski TJ; Krensky AM
    J Immunol; 1997 Mar; 158(6):2680-8. PubMed ID: 9058801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECH, an epoxycyclohexenone derivative that specifically inhibits Fas ligand-dependent apoptosis in CTL-mediated cytotoxicity.
    Mitsui T; Miyake Y; Kakeya H; Osada H; Kataoka T
    J Immunol; 2004 Mar; 172(6):3428-36. PubMed ID: 15004142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cdelta regulates antigen receptor-induced lytic granule polarization in mouse CD8+ CTL.
    Ma JS; Monu N; Shen DT; Mecklenbräuker I; Radoja N; Haydar TF; Leitges M; Frey AB; Vukmanovic S; Radoja S
    J Immunol; 2007 Jun; 178(12):7814-21. PubMed ID: 17548619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K; Akashi A; Arai S
    Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of primary CD8+ cytotoxic T lymphocytes to lysis by cytotoxic granules from cloned T cell lines.
    Nagler-Anderson C; Verret CR; Firmenich AA; Berne M; Eisen HN
    J Immunol; 1988 Nov; 141(10):3299-305. PubMed ID: 2972770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway.
    Isaaz S; Baetz K; Olsen K; Podack E; Griffiths GM
    Eur J Immunol; 1995 Apr; 25(4):1071-9. PubMed ID: 7737276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro.
    Berke G; Rosen D
    J Immunol; 1988 Sep; 141(5):1429-36. PubMed ID: 3261748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis.
    Radoja S; Saio M; Schaer D; Koneru M; Vukmanovic S; Frey AB
    J Immunol; 2001 Nov; 167(9):5042-51. PubMed ID: 11673513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poxvirus-encoded serpins do not prevent cytolytic T cell-mediated recovery from primary infections.
    Müllbacher A; Wallich R; Moyer RW; Simon MM
    J Immunol; 1999 Jun; 162(12):7315-21. PubMed ID: 10358181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.
    Baetz K; Isaaz S; Griffiths GM
    J Immunol; 1995 Jun; 154(11):6122-31. PubMed ID: 7751653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High DGK-α and disabled MAPK pathways cause dysfunction of human tumor-infiltrating CD8+ T cells that is reversible by pharmacologic intervention.
    Prinz PU; Mendler AN; Masouris I; Durner L; Oberneder R; Noessner E
    J Immunol; 2012 Jun; 188(12):5990-6000. PubMed ID: 22573804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.